×
About 431 results

ALLMedicine™ Chromoblastomycosis Center

Research & Reviews  211 results

Doubly Misdiagnosed: Exophiala Masquerading as Squamous Cell Carcinoma and Chromoblasto...
https://doi.org/10.1097/DAD.0000000000001994
The American Journal of Dermatopathology; Guerra R, Guffey D et. al.

Jun 4th, 2021 - Deep cutaneous fungal infections (DCFI) can arise in the setting of skin trauma and immunosuppression. DCFI may be secondary to chromoblastomycosis, which is typically characterized by pseudoepitheliomatous hyperplasia histologically and can be mi...

Effect of melanin biosynthesis inhibition in the antifungal susceptibility of chromobla...
https://doi.org/10.1128/AAC.00546-21
Antimicrobial Agents and Chemotherapy; Heidrich D, Pagani DM et. al.

May 11th, 2021 - Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by genera of melanized fungi: Fonsecaea, Cladophialophora, Phialophora, Exophiala and Rhinocladiella Melanin is a virulence factor known to influence antifungal susceptibility. A...

The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical d...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872288
PLoS Neglected Tropical Diseases; Nargesi S, Bongomin F et. al.

Feb 9th, 2021 - The World Health Organization (WHO) considers mycetoma, chromoblastomycosis, and paracoccidioidomycosis to be fungal neglected tropical diseases (FNTDs). Depending on climatic, cultural, and economic contexts, these diseases have a similar geograp...

Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi usin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710028
PloS One; Koehler A, Corbellini VA et. al.

Dec 2nd, 2020 - Fonsecaea pedrosoi is one of the main agents of chromoblastomycosis, a chronic subcutaneous mycosis. Itraconazole (ITC) is the most used antifungal in its treatment, however, in vitro antifungal susceptibility tests are important to define the bes...

Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar.
https://doi.org/10.1016/j.ijid.2020.09.1479
International Journal of Infectious Diseases : IJID : Off... Sendrasoa FA, Razanakoto NH et. al.

Oct 4th, 2020 - To describe the clinical aspects of chromoblastomycosis (CBM) presented by patients who had received incomplete antifungal treatment before consultation. A prospective study of patients with clinically suspected CBM was performed between 2013 and ...

see more →

Clinicaltrials.gov  211 results

Doubly Misdiagnosed: Exophiala Masquerading as Squamous Cell Carcinoma and Chromoblasto...
https://doi.org/10.1097/DAD.0000000000001994
The American Journal of Dermatopathology; Guerra R, Guffey D et. al.

Jun 4th, 2021 - Deep cutaneous fungal infections (DCFI) can arise in the setting of skin trauma and immunosuppression. DCFI may be secondary to chromoblastomycosis, which is typically characterized by pseudoepitheliomatous hyperplasia histologically and can be mi...

Effect of melanin biosynthesis inhibition in the antifungal susceptibility of chromobla...
https://doi.org/10.1128/AAC.00546-21
Antimicrobial Agents and Chemotherapy; Heidrich D, Pagani DM et. al.

May 11th, 2021 - Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by genera of melanized fungi: Fonsecaea, Cladophialophora, Phialophora, Exophiala and Rhinocladiella Melanin is a virulence factor known to influence antifungal susceptibility. A...

The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical d...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872288
PLoS Neglected Tropical Diseases; Nargesi S, Bongomin F et. al.

Feb 9th, 2021 - The World Health Organization (WHO) considers mycetoma, chromoblastomycosis, and paracoccidioidomycosis to be fungal neglected tropical diseases (FNTDs). Depending on climatic, cultural, and economic contexts, these diseases have a similar geograp...

Prediction of itraconazole minimum inhibitory concentration for Fonsecaea pedrosoi usin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710028
PloS One; Koehler A, Corbellini VA et. al.

Dec 2nd, 2020 - Fonsecaea pedrosoi is one of the main agents of chromoblastomycosis, a chronic subcutaneous mycosis. Itraconazole (ITC) is the most used antifungal in its treatment, however, in vitro antifungal susceptibility tests are important to define the bes...

Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar.
https://doi.org/10.1016/j.ijid.2020.09.1479
International Journal of Infectious Diseases : IJID : Off... Sendrasoa FA, Razanakoto NH et. al.

Oct 4th, 2020 - To describe the clinical aspects of chromoblastomycosis (CBM) presented by patients who had received incomplete antifungal treatment before consultation. A prospective study of patients with clinically suspected CBM was performed between 2013 and ...

see more →

News  9 results

Uncommon Presentation of Chromoblastomycosis
https://www.mdedge.com/dermatology/article/167540/infectious-diseases/uncommon-presentation-chromoblastomycosis/page/0/1

Jun 7th, 2018 - Comment Distribution Chromoblastomycosis, also known as chromomycosis and verrucous dermatitis,3 is a chronic subcutaneous mycosis found in tropical and subtropical regions. 3,4 It is caused by traumatic inoculation of any of several members of a s.

Chromoblastomycosis Infection From a House Plant
https://www.mdedge.com/dermatology/article/149755/infectious-diseases/chromoblastomycosis-infection-house-plant
Gerard Smith, MD, Andrea F. Chen, MD et. al.

Oct 18th, 2017 - To the Editor: A 69-year-old woman with no history of immunodeficiency presented 1 month after a thorn from her locally grown Madagascar palm plant (Pachypodium lamerei) pierced the skin. The patient developed a painful nodule at the site on the l.

Physical treatment plus antifungal best for chromoblastomycosis, review finds
https://www.mdedge.com/infectiousdisease/article/138818/infectious-diseases/physical-treatment-plus-antifungal-best
Bianca Nogrady

May 23rd, 2017 - SYDNEY – Chromoblastomycosis is best managed with a combination of surgery or cryotherapy, with an antifungal, based on a systematic review of 37 studies. The results of these studies, none of which was randomized or controlled, highlighted challe.

Chromoblastomycosis
https://www.mdedge.com/node/103495/path_term/51947
Alison Spiker, MD, Tammie Ferringer, MD

Oct 13th, 2015 - Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissues that demonstrates characteristic Medlar or sclerotic bodies that resemble copper pennies on histopathology. 1 Cutaneous infection often results from direct inocu.

see more →